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Streptococcus dysgalactiae subsp. equisimilis (groups 
C and G streptococci [GCS/GGS]) is an increasingly rec-
ognized human pathogen, although it may follow indirect 
pathways. Prospective surveillance of selected households 
in 3 remote Aboriginal communities in Australia provided 
337 GCS/GGS isolates that were emm sequence-typed. 
Lancefi eld group C isolates (GCS) were localized to specifi c 
households and group G isolates (GGS) were more evenly 
distributed. GCS/GGS was more frequently recovered from 
the throat than group A streptococci (GAS [S. pyogenes]) but 
rarely recovered from skin sores, and then only with Staphy-
lococcus aureus or GAS. Symptomatic GGS/GGC pharyngi-
tis was also rare. Specifi c emm sequence types of GCS/GGS 
did not appear to cycle through the communities (sequen-
tial strain replacement) in a manner suggesting acquisition 
of type-specifi c immunity. These communities already have 
high levels of streptococcal and poststreptococcal disease. 
GCS/GGS may increase in importance as it acquires key 
virulence factors from GAS by lateral gene transfer.
In 1933, Rebecca Lancefi eld described a precipitin reac-tion that differentiated β-hemolytic streptococci into sev-
eral groups according to the group-specifi c carbohydrate; 
these included groups A to E and unclassifi ed strains (1). 
The isolates of group C streptococci (GCS) she investi-
gated were of animal origin. Group G streptococci (GGS) 
were subsequently recognized in vaginal swabs from par-
turient women (2) and, for much of the next 50 years, GCS 
and GGS were considered to be nonpathogenic fl ora of the 
throat, gut, and vagina. When it became apparent that GCS 
and GGS could be human pathogens, it also emerged that 
they were a diverse group of streptococci consisting of at 
least 4 species, Streptococcus anginosus, S. equi, S. equi-
similis, and S. zooepidemicus (3). In contrast, with few ex-
ceptions, group A streptococci (GAS) belong to 1 species, 
S. pyogenes. 
Certain strains of GCS and GGS have been increas-
ingly reported to cause infections similar to those caused 
by GAS such as pharyngitis, sepsis, skin and soft tissue 
infection, toxic shock, reactive arthritis, and postinfectious 
glomerulonephritis (3). Similar to GAS, human strains of 
GCS and GGS tend to have large colonies and a hyaluronic 
acid capsule; they also produce M protein that has struc-
tural, immunochemical, and biologic features similar to the 
M protein of GAS (4). Subsequent studies of the bacterial 
genome, including multilocus sequence typing of house-
keeping genes, has demonstrated that large colony–form-
ing human GCS and GGS are members of 1 species, S. dys-
galactiae subsp. equisimilis (GCS/GGS) (5).
As with GAS, the M protein of GCS/GGS is respon-
sible for resistance to phagocytosis (4). There is extensive 
sequence homology between gene sequences of  GCS/GGS 
M protein and the emm gene of GAS; sequence heterogene-
ity at the 5′ end results in distinct emm sequence types (6). 
More than 35 years ago, Widdowson et al. recognized 2 
M protein–related antigenic groups (I and II) in GAS that 
matched known skin and throat M serotypes (7). Skin types 
were subsequently found to have a cell surface lipoprotein-
ase that binds fi bronectin and causes opacity in horse serum 
(serum opacity factor [SOF]) (8). SOF is absent from iden-
tifi ed rheumatogenic M types. 
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Using molecular techniques to differentiate M protein 
classes, Bessen et al. found that class I strains show a cor-
relation with SOF-negative strains and contain serotypes 
associated with acute rheumatic fever (ARF) (9), whereas 
class II strains are associated with skin tropism. GCS/GGS 
only possesses class I M protein with a surface-exposed con-
served region similar to M protein of known rheumatogenic 
GAS strains (4). Most human GCS/GGS appear to be SOF 
negative, although SOF-positive emm types (stG166b.0 and 
stG480.0) have been reported (10). Although there are no 
published cases of ARF proven to have been caused by GCS/
GGS, M protein characteristics of GCS/GGS probably play 
a role in clinical disease and tissue tropism, and suggest the 
potential for rheumatogenicity (11).
We conducted this study in Aboriginal communities 
of tropical Australia in which rates of ARF and rheumatic 
heart disease (RHD) are among the highest reported; how-
ever, in this region streptococcal pharyngitis is apparently 
rare and pyoderma is common (12). Outbreaks of acute 
poststreptococcal glomerulonephritis (APSGN) are also 
common (13). The primary aim of the study was to inves-
tigate the epidemiology of β-hemolytic streptococci and 
to determine whether there are unique aspects applicable 
to the pathogenesis of ARF/RHD. We also used molecu-
lar typing to specifi cally characterize the epidemiology of 
GCS/GGS throat carriage, pharyngitis, and skin infection 
in these communities and to examine their relationship to 
GAS epidemiology and ARF.
Methods
Community Surveillance
The study was conducted in 3 remote Aboriginal com-
munities located in the northern part of Northern Territory 
in Australia in which the prevalence of RHD was >25 per 
1,000 population compared with <1 per 1,000 in the non-
Aboriginal population. Community consultation, ethical 
approval (Human Research and Ethics Committee of the 
Northern Territory Department of Health and Community 
Services and Menzies School of Health Research, Darwin, 
Australia), household enrollment, data collection, and sur-
veillance for ARF have been reported in detail (12). Sur-
veillance was conducted in community 1 from July 2003 
through June 2005, community 2 from July 2003 through 
June 2004, and in community 3 from July 2004 through 
June 2005. Local logistic problems restricted data collec-
tion in community 2. Community 1 is ≈500 km from com-
munity 2 and 700 km from community 3. The communi-
ties’ names have not been used at their request.
A high degree of day-to-day population mobility pre-
vented regular follow-up of persons over an extended pe-
riod. Households were representative of family groupings 
and were studied as distinct epidemiologic units. Study 
households were selected on the basis that at least 1 occu-
pant had a known history of ARF or RHD; this was done to 
increase chances of encountering additional cases of ARF. 
A household was defi ned as a family group that lived in 1 
house or 2 adjacent houses. Persons were considered to be-
long to a household if they said they belonged at enrollment 
and were present on at least 2 subsequent visits. Crowding 
was based on the number of occupants per bedroom.
We attempted to visit each household on a monthly ba-
sis. At each visit, all children and adults present were ques-
tioned about sore throat and skin sores. All throats were ex-
amined and swabbed for culture, limbs and exposed areas 
were examined, and pyoderma lesions were also swabbed. 
Each personal contact was called a consultation.
Laboratory Methods
Specimen transportation, culture methods, and species 
identifi cation have been described (14). Only large colo-
ny–forming β-hemolytic streptococci were selected and 
Lancefi eld grouped by using a Streptococcal Grouping Kit 
(Oxoid Diagnostic Reagents, Basingstoke, United King-
dom); suspected GAS isolates were tested for pyrrolidonyl 
arylamidase. Care was taken to exclude groups A, C, and 
G isolates of S. anginosus (15). Occasionally, S. anginosus 
morphology and β-hemolysis resembled that of GAS, but 
when colonies were streaked out and incubated overnight, 
the plates had a distinctive caramel odor. S. anginosis also 
failed to provide a PCR product for emm sequence typing.
The procedures for emm sequence typing followed 
those of the Centers for Disease Control and Prevention 
(CDC) (Atlanta, GA, USA) (10) with minor modifi cations. 
Seqman software (DNASTAR Inc., Madison, WI, USA) 
was used for sequence analysis and results were compared 
with the CDC emm sequence database. New emm sequence 
subtypes were assigned by the moderator. In this article, an 
emmST refers to an emm sequence subtype. We also exam-
ined the translated emm sequences for plasminogen binding 
A repeats to identify emmSTs of the plasminogen binding 
M-like protein (PAM) phenotype (16).
Data Analysis
Epidemiologic data were analyzed by using Stata 8 
(Stata Corporation, College Station, TX, USA). Confi -
dence intervals were calculated by using standard meth-
ods. Correlation of household crowding and carriage was 
done by using Pearson correlation coeffi cient. Because of 
variability in household visits and the number of persons 
present at each visit, recovery rates were expressed per 100 
consultations.
Results
We enrolled 49 households and made 531 household 
visits. These households provided 4,841 throat swabs and 
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484 skin sore swabs from 420 episodes of pyoderma. Lim-
ited data were obtained from community 2, and most of 
the comparative analysis was done between communities 
1 (population ≈2,500) and 3 (population ≈1,800). These 
communities are truly remote, being accessible only by air 
for much of the wet season (December to April).
We identifi ed and emm sequence-typed 350 isolates 
of GAS, 80 isolates of GCS, and 257 of GGS (Table 1). 
Four new GCS/GGS nucleotide sequence subtypes were 
described (GenBank accession nos. in parentheses): 
stC839.2 (AM403090), stC1400.3 (AM403091) stC1400.4 
(AM403092), and stG480.3 (AM403093). GGS was iso-
lated from only 1 child with a sore throat; this isolate was 
stG6792.0, one of the most common types. GGS/GCS was 
recovered from persons with 9 episodes of pyoderma, but 
always with Staphylococcus aureus, and in 2 persons with 
GAS. There were 7 different emmSTs identifi ed in skin 
swabs; most belonged to common types.
GCS were distributed unevenly (Table 1). The recov-
ery rate for community 1 was 10 times that for community 
3. Recovery rates for GGS and GAS across the communi-
ties were more even (17), which suggested that that the dif-
ference observed for GCS may be real. Throat swab sam-
ples from 154 (23.9%) children (those <15 years of age) 
had GCS/GGS, and samples from 126 (19.5%) children 
had GAS. Although GGS was more prevalent in commu-
nity 1, there was greater diversity of emmSTs in commu-
nity 3, with 15 different emmSTs compared with 9 differ-
ent emmSTs in community 1. Month-to-month recovery 
rates varied widely with medians of 3.3 (interquartile range 
[IQR] 1.2–3.3) per 100 consultations for GCS and 5.0 (IQR 
3.4–7.5) for GGS in community 1, and 3.6 (IQR 1.6–5.9) 
for GGS in community 3. There was no apparent seasonal 
variation, although recovery rates of GCS, GGS, and GAS 
from throat swab samples peaked together in communities 
1 and 3 during May 2005. A region-wide APSGN outbreak 
at that time was attributed to GAS emm55.0 (18), but re-
covery rates of GCS stG643.0, GGS stC1400.0, and GGS 
stC74a.0 also increased sharply (Figure 1). This fi nding 
went largely unnoticed until emm typing of GCS/GGS was 
completed >12 months later.
The age distribution of GCS/GGS throat carriage in 
these communities was similar to that of GAS, with the 
highest recovery rates in 5- to 9-year-old children and 10- 
to 14-year-old children (12). However, different emmSTs 
of GCS/GGS did not appear to cycle through the commu-
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Table 1. Streptococcal emm sequence subypes (STs) of study isolates by Lancefield type in 3 communities, Northern Territory, 
Australia* 
Community 1 Community 2 Community 3 
Subtype No. Rate† No. Rate† No. Rate† Total Total rate† 
GCS emmST 
 stC839.0 29 0.96 29 0.60
 stG643.0 26 0.86 26 0.54
 stGrobn.0 9 0.30 9 0.19
 stC6979.0 8 0.26 1 0.07 9 0.19
 stC839.2 4 0.16 4 0.08
 stC6746.0 1 0.03 1 0.07 2 0.04
 stC2sk.1 1 0.07 1 0.02
 Total 77 2.54 – – 3 0.20 80 1.65
GGS emmST
 stC1400.0 34 1.13 5 1.69 27 1.76 66 1.36
 stG4831.0 34 1.13 7 0.46 41 0.85
 stG480.0 28 0.93 10 0.65 38 0.78
 stG6792.0 35 1.16 1 0.34 1 0.07 37 0.76
 stC74a.0 25 0.83 1 0.34 3 0.20 29 0.60
 stC6979.0 8 0.26 2 0.13 10 0.21
 stC5344.1 9 0.30 9 0.19
 stG6.0 6 0.39 6 0.12
 stG10.0 5 0.33 5 0.10
 stG2078.0 4 0.26 4 0.08
 stC.NSRT2.0 1 0.03 2 0.13 3 0.06
 stC36.0 3 0.20 3 0.06
 stC1400.4 2 0.13 2 0.04
 stC1400.3 1 0.07 1 0.02
 stG166b.0 1 0.07 1 0.02
 stG480.3 1 0.07 1 0.02
 stG652.0 1 0.03 1 0.02
 Total 175 5.76 7 2.37 75 4.90 257 5.30
*GCS, group C streptococci; GGS, group G streptococci. Lancefield type and emmSTs do not always match and stC6979 can be either GCC or GGC. 
†Per 100 consultations. 
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nity in the same way as GAS (Figure 1) (17). There was no 
evidence of sequential emmST replacement. It was diffi cult 
to follow persons month by month, although we did iden-
tify a child who had GCS stC839.0 in throat samples on 11 
occasions over 14 months and a household that harbored 
GGS stG4831.0 for at least 18 months. GCS appeared to be 
highly prevalent (>5.0/100 consultations) in 3 households 
in community 1 yet was absent from 3 others in the same 
community. There was poor correlation between recov-
ery rates of both GCS and GGS and household crowding 
(r = 0.24).
When GCS/GGS throat isolates were compared with 
GAS throat isolates, they appeared to be almost mutually 
exclusive (Figure 2); on only 14 occasions were GAS and 
GCS or GGS recovered together. The emmSTs of the 15 
isolates (1 child had GAS, GCS, and GGS) were represen-
tative of the whole GCS/GGS population (Table 2) and no 
emmST was dominant. These results are consistent with 
the assumption that throat carriage of GAS and carriage 
of GCS/GGS are independent of each another. However, 
on further investigation, this did not appear to be true. Per-
sons with a positive throat culture for GAS during the study 
were more likely to have a positive culture for GCS/GGS 
than those who never had GAS recovered from the throat 
(65 [36%] of 180, 95% confi dence interval [CI] 22%–33% 
compared with 168 [17%] of 993, 95% CI 15%–19%, rela-
tive risk 2.3, 95% CI 1.7–3.0). The relative risk for persons 
who had >6 throat swabs taken over the course of the study 
and for those who had <6 swabs taken was the same. We 
observed a poor correlation between household recovery 
rates of GAS and GCS/GGS (r = 0.39 for community 1 and 
r = 0.16 for community 2).
There was a marked discrepancy between β-hemolytic 
streptococcal recovery rates from the throat and the skin. 
GCS/GGS comprised 328 (60%) of 548 throat isolates (95% 
CI 56%–64%) and 9 (6.9%) of 131 skin isolates (95% CI 
3.2%–12.6%) skin isolates. Sequence analysis of GCS/GGS 
emm showed that all isolates from throat and skin samples 
were negative for the skin-tropic determinant PAM.
Table 1 shows that 2 emmSTs with group C carbohy-
drate by Lancefi eld typing had group G emm sequences 
(stG643.0 and stGrobn.0) as determined by using the CDC 
database (10). Likewise, 8 GGS (stC1400.0, stC74a.0, 
stC6979.0, stC5344.1, stCNSRT2.0,  stC36.0, stC1400.3, 
and stC1400.4) belonged to emmST with GCS character-
istics. Of 19 stC6979.0 isolates, 9 were GCS and 10 were 
GGS. In May 2004, GCS stC6979.0 and GGS stC6979.0 
were isolated from 2 persons in the same household. Ini-
tial investigation of the distribution of virulence genes in 
these isolates suggests that the GCS and GGS stC6979.0 
are 2 distinct strains. Further studies to differentiate them 
are under way.
Discussion
The reported prevalence of GCS/GGS carriage and in-
cidence of related disease varies greatly worldwide. Most 
studies originate from temporal climate regions of the 
Northern Hemisphere and limited data are available from 
tropical regions. In the minds of most researchers and clini-
cians, the contributory role of GCS/GGS to acute pharyn-
gitis is consistent with supporting evidence from numer-
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Figure 1. Monthly recovery rates of most common Streptococcus 
dysgalactiae subsp. equisimilis (group C and group G streptococci) 
emm sequence subtypes (STs) in community 1, Northern Territory, 
Australia. Values along the y-axes are no. bacterial isolates per 100 
consultations. No obvious pattern of sequential strain replacement 
was seen as with Streptococcus pyogenes (group A streptococci) 
(17). 
Figure 2. Venn diagram of positive throat swabs, Northern 
Territory, Australia, showing that group A streptococci (GAS) and 
Streptococcus dysgalactiae subsp. equisimilis (GCS/GGS) appear 
almost mutually exclusive. Thirteen persons had GAS and GCS or 
GGS, and 1 child had GAS, GCS, and GGS. 
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ous studies, albeit of varying quality (19, 20). Outbreaks 
of GCS/GGS-related disease have also been reported (21). 
However, several studies, some of good quality, are less 
supportive of this view (22,23). Our surveillance failed to 
produce convincing evidence of GAS pharyngitis in chil-
dren of these communities (12) and GCS/GGS pharyngi-
tis. We did show that GCS/GGS is more commonly found 
in the throat than GAS. Moreover, study participants who 
carried GAS at any time were more likely at some stage 
to carry GCS/GGS. The link is probably household envi-
ronmental factors, but there may be a streptococcal carrier 
phenotype (24). There is no evidence from our data that 
GCS/GGS displaces GAS from the throat.
Reported rates for throat carriage of GCS ranged from 
0% to 12% in 1 Finnish community (25) and from 0% to 
9.3% in Indian schoolchildren (26). GGS throat carriage 
was more common than GAS in this study (12); this was 
also true for Indian and Bangladeshi schoolchildren (26,27) 
and a Nigerian community (28). However, results of stud-
ies conducted >10 years ago should be interpreted with 
caution because of previous taxonomic confusion with fail-
ure to distinguish small and large colony forms of GCG 
and GGS.
Throat carriage of GCS/GGS, as distinct from car-
riage of GAS, was quite uneven. GCS was concentrated 
in a few households in community 1 where long-term car-
riage was common, but GCS was nearly absent from com-
munity 3. The reason for this absence is unknown. GGS 
was more evenly distributed across the communities, but 
more highly concentrated in specifi c households. The com-
munity pattern of sequential strain replacement seen with 
GAS (24,29) was absent, which suggests that acquisition of 
M protein type–specifi c immunity against GCS/GGS may 
not play a role in these communities. There is no evidence 
that type-specifi c immunity is protective against GCS/GGS 
(5,30). In addition, we observed no seasonal variation of 
GAS carriage (12).
Although these isolates were recovered from persons 
in remote communities of Australia and new subtypes of 
established emm types were found, no new emm STs were 
found. Until now, there has been little published informa-
tion regarding the existing scope of emm types of GCS/
GGS. The fi ndings of this study suggest that there may not 
be a huge diversity, at least not to the extent that is seen 
with GAS.
The degree of throat tropism of GCS/GGS and lack of 
independent skin pathogenicity was a conspicuous fi nding. 
GCS/GGS causes many diseases similar to GAS, including 
skin and soft tissue infection (3), but reports of childhood 
pyoderma are few. GGS was found in 3% of pyoderma le-
sions in an Indian study, but always with S. aureus (31). 
Similar rates were reported from children in Trinidad (32). 
A West African study reported a 16% recovery rate of 
GGS from pyoderma (28), but this study was conducted 
>35 years ago. APSGN has been associated with GCS/
GGS pyoderma in Trinidad (32), although the evidence for 
causation is tenuous. The Top End outbreak of APSGN in 
May 2005 in the Northern Territory of Australia was not 
associated with an increase in GCS/GGS skin infection in 
study communities. However, an apparent but unexplained 
increase in throat carriage of GCS/GGS occurred during 
this period, concomitant with increased throat carriage and 
skin recovery of GAS (17).
Although GCS/GGS has class I M protein, other fac-
tors could account for the observed tropism. In GAS, PAM 
is associated with skin tropism and emm pattern type D 
(33). An animal model of pyoderma suggests that skin in-
fection with these strains requires streptokinase and PAM-
bound plasminogen (34). However, other mechanisms 
must be involved because pyoderma can also be caused by 
non-PAM pattern D types and other emm pattern types. The 
GCG/GGS isolates in this study, as elsewhere, lack PAM. 
The critical gene for streptokinase activity in GAS, ska (the 
subcluster 2b β-domain), may have been acquired from 
GCS/GGS by lateral gene transfer (33).
There is additional evidence for lateral gene transfer 
with rofA and related genes. The gene encoding the key 
determinant for GAS binding to skin fi broblast fi bronectin, 
SfbI, is located in a highly recombinatorial region of the 
GAS genome (35). The sfbI gene has a homolog, gfbA, in 
GCS/GGS that is likely a product of horizontal gene trans-
fer and recombination (36). The role of fi bronectin binding 
in skin and soft tissue infection has yet to be elucidated. 
The rofA gene is a positive regulator of sfbI and is present 
in GAS emm patterns types A–C and E, but is less common 
in pattern type D. GAS rofA is another gene that was pos-
sibly acquired from GCS/GGS by horizontal gene transfer 
(37). GAS emm patterns A–C are more phylogenetically 
primitive and less genetically diverse (38) than emm pat-
tern types D and E. The throat may have been the original 
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Table 2. Streptococcus dysgalactiae subsp. equisimilis emm
sequence subtypes (STs) of 15 isolates from 3 communities, 
Northern Territory, Australia* 
Subtype No. isolates
GCS emmST 
stC2sk.1 1
stC839.0 2
stGrobn.0 1
GGS emmST
stC-NSRT2.0 1
stC1400.0 3
stC1400.3 1
stC74a.0 3
stG480.0 1
st4831.0 1
stG6.0 1
*Isolates obtained from throat swab samples that also contained S.
pyogenes. GCS, group C streptococci; GGS, group G streptococci. 
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niche for human colonization with GAS, and the ability to 
cause skin infection may be a more recently acquired trait.
Studies of bacterial housekeeping genes indicate that 
most gene traffi c is toward GCS/GGS from GAS (5) and 
importation of GAS alleles into GCS/GGS is a relatively 
recent event. GAS is a completely human-adapted organ-
ism and human strains of GCS/GCS are more likely to be 
related to their animal fl ora origins. Humans may have ac-
quired specifi c strains of GCS/GCS through animal domes-
tication and these bacteria are now becoming human-adapt-
ed; 1 mechanism appears to be through phage-mediated 
acquisition of GAS alleles (5). There is some evidence that 
this process is more intense where the community strepto-
coccal burden is high and strain turnover is rapid, such as in 
remote Aboriginal communities of the Northern Territory 
(39). If this is true, we could witness a regional increase in 
virulence of GCS/GGS over time, possibly including ac-
quisition of rheumatogenic determinants. 
Evidence is lacking that GCS/GGS causes ARF. 
Nonetheless, mouse antibodies to GCS/GGS M protein 
react with human cardiac myosin (11), and levels of anti-
bodies to streptolysin O and hyaluronic acid increase after 
infection with GCS/GGS (3). ARF is driven by an exag-
gerated immune response to as-yet-undefi ned streptococ-
cal epitopes, with possible immune priming from sequen-
tial streptococcal infections (40). An immune response to 
GCS/GGS, whether or not it is protective, may contribute 
to the priming process even if subsequent GAS infection is 
an absolute requirement for ARF.
We did not fi nd a comparable study that examined 
the community and household dynamics of GCS/GGS 
carriage. Our study was originally intended as a longitudi-
nal cohort study. However, the high population mobility, 
household turnover, and disruption of local community 
events compromised longitudinal surveillance (12,17). As 
such, the study became a series of point prevalence ob-
servations with accompanying data limitations. The study 
focused on households rather than persons, given the tran-
sience of the population, and we looked actively for throat 
and skin infection rather than waiting for presentation at 
the community health center. There were potential prob-
lems with variability of specimen collection and process-
ing, and the lack of data from community 2 necessitated 
a move to community 3. We investigated selected study 
households, which may not have been representative of 
the whole community. 
Because there is a relatively poor correlation between 
emm sequence type and GCS/GGS clone than with GAS 
(5), epidemiologic studies of GCS/GGS based on emm typ-
ing may need to be supplemented by techniques such as 
multilocus sequence typing, which defi ne clonal type. Like-
wise, Lancefi eld grouping provides useful information, but 
is an unreliable epidemiologic tool unless supplemented by 
other methods. Nevertheless, the prospective nature of this 
study, and its size, make it likely that its fi ndings provide 
a reasonable representation of the true epidemiology of 
GCS/GGS in this population. GCS/GGS was common in 
remote Aboriginal communities with high rates of strepto-
coccal disease. Its contribution to illness, and even death, 
may manifest through indirect pathways, some of which 
have yet to be determined.
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